Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000082276

Meso Scale Discovery U-PLEX Human CRP ASY
SDP

Catalog No. 5000082276
Encompass

The Meso Scale Discovery U-PLEX Human CRP Assay is an electrochemiluminescent immunoassay for the quantitative measurement of C-reactive protein (CRP) in human serum plasma and cell culture supernatant The assay uses MSD s proprietary SULFO-TAG labels and multi-array technology to provide a highly sensitive and reproducible method for detecting CRP levels between 0 04 - 2500 ng/mL This assay can be used to aid in evaluation of inflammatory conditions and infections The kit includes a 96-well plate coated with capture antibody detection antibody calibrator diluent wash buffer read buffer and SULFO-TAG labeled detection antibody

Catalog No. 50-000-82276 Supplier Meso Scale Discovery Supplier No. K151L9K1
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

The Meso Scale Discovery U-PLEX Human CRP Assay is an electrochemiluminescent immunoassay for the quantitative measurement of C-reactive protein (CRP) in human serum plasma and cell culture supernatant The assay uses MSD s proprietary SULFO-TAG labels and multi-array technology to provide a highly sensitive and reproducible method for detecting CRP levels between 0 04 - 2500 ng/mL This assay can be used to aid in evaluation of inflammatory conditions and infections The kit includes a 96-well plate coated with capture antibody detection antibody calibrator diluent wash buffer read buffer and SULFO-TAG labeled detection antibody

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.